Spectral Diagnostics (OTCMKTS:EDTXF) Trading Up 0.5% - Here's Why

Key Points

• Spectral Diagnostics Inc. shares increased 0.5% during mid-day trading, with the stock last trading at $1.10.
• The company's market cap stands at $316.75 million and has a price-to-earnings ratio of -15.71.
• Spectral Medical focuses on products for treating septic shock, including a rapid diagnostic test and a therapeutic hemoperfusion device.

Spectral Diagnostics Inc. (OTCMKTS:EDTXF - ) shares were up 0.5% during mid-day trading on Monday . The stock traded as high as $1.14 and last traded at $1.10. Approximately 3,354 shares changed hands during mid-day trading, a decline of 65% from the average daily volume of 9,689 shares. The stock had previously closed at $1.10.

Spectral Diagnostics Trading Up 0.5%

The stock's 50-day moving average is $1.04 and its 200-day moving average is $0.75. The company has a market cap of $316.75 million, a price-to-earnings ratio of -15.71 and a beta of 0.18.

About Spectral Diagnostics

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.